Global Topical Drug Delivery Market – Industry Trends - Forecast to 2026

  • Pharmaceutical
  • Published Report
  • May 2019
  • Global
  • 246 Pages
  • No of Tables: 17
  • No of Figures: 271

Global Topical Drug Delivery Market By Product Type (Formulations,( {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches, Gels)}), Application of Drug (Skin Drug, Ophthalmic Drug, Rectal Drug, Vaginal Drug, Nasal Drug), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail);Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Analysis: Global Topical Drug Delivery Market

Global Topical Drug Delivery Market is expected to rise from its initial estimated value of USD 120.82 billion in 2018 to an estimated value of USD 240.76 billion by 2026, registering a CAGR of 9.00% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing  preference for topical drug delivery.

Market Definition: Global Topical Drug Delivery Market

Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired unfavourable effect of a drug is dependent on the concentration of the drug at the place of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action.

According to World Health Organization, there were an estimated 9.6 million deaths in 2018 due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical for healthcare procedures. This significant number is expected to act as a driver to the market growth

Market Drivers

  • There is high demand for prevalence of skin diseases is expected to act as a driver to the market growth
  • High growing preference for topical drug delivery is also expected to act as a driver to the market growth
  • There is increase in incidence of burn injuries is also expected to act as a driver to the market growth

  • Rising incidence of diabetes is also to drive the market

Market Restraints

  • Negative impact of product recalls is expected to restrain the market growth.

Segmentation: Global Topical Drug Delivery Market

By Product Type

  • Topical

    • Solid Topical Formulations

      • Suppositories
      • Powders

    • Semi-Solid Topical Formulations

      • Creams
      • Gels
      • Ointments
      • Pastes
      • Lotions

    • Liquid Topical Formulations

      • Solutions
      • Suspensions

  • Transdermal

    • Patches
    • Gels

By Application of Drug

  • Skin Drug
  • Ophthalmic Drug
  • Rectal Drug
  • Vaginal Drug
  • Nasal Drug

By End User

  • Hospitals and Private Clinics
  • Home Care Settings
  • Other

By Distribution Channel

  • Direct Tenders
  • Retail

By Geography

  • North America

    • US.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Argentina
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • Middle East & Africa

    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In December 2018,Aclaris Therapeutics Acquired RHOFADE® from Allergan. RHOFADE cream was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults. By this acquisition Aclaris to further strengthen itself in topical treatments.
  • In December 2018, Sun Pharma acquires Pola Pharma’s two manufacturing plants. Pola Pharma is a topical drug and injectables manufacture in Japan. By this acquisition sun Pharma to further strengthen its presence in Japan.

Competitive Analysis: Global Topical Drug Delivery Market

Global topical drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of topical drug delivery market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Topical Drug Delivery Market

Few of the major competitors currently working in the nerve repair biomaterial market are Galderma S.A. (Switzerland), GlaxoSmithKline plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Crescita Therapeutics Inc. (Canada), Medpharm (U.K.), 3M (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Janssen Global Services, LLC (U.S.), Cipla Inc. (India), West Pharmaceutical Services ,Inc (US), Biofarmitalia s.r.l (Italy), Pharmatek Laboratories, Inc. (US), Stiefel Laboratories, Inc. (US), Tapemark (US), Acrux Limited (Australia), Nitto Denko Corporation (Japan), Skinvisible Pharmaceuticals, Inc. (us), Mylan N.V. (US), Pocono Coated Products LLC (US), Lohmann Therapie-Systeme AG (Germany).

 Research Methodology: Global Topical Drug Delivery Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your inquiry.

The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global topical drug delivery market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

SKU-

LIST OF TABLE GLOBAL TOPICAL DRUG DELIVERY MARKET

TABLE 1 LIST OF APPROVED TOPICAL DRUGS TABLE 2 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 3 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 4 GLOBAL TDDF MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 5 GLOBAL LIQUID TDDF MARKET, BY PRODUCT TYPE, 2015– 2024(USD BILLION) TABLE 6 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION) TABLE 7 GLOBAL TDDS MARKET, BY PRODUCT TYPE, 2015– 2024 (USD BILLION) TABLE 8 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 9 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2014 – 2024 (USD BILLION) TABLE 10 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 11 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION) TABLE 12 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY, 2015 – 2024 (USD BILLION) TABLE 13 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 14 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD BILLION) TABLE 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 16 NORTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 17 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 18 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 19 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD BILLION) TABLE 20 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 21 NORTH AMERICA ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 22 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION) TABLE 23 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD BILLION) TABLE 24 U.S. TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 25 U.S. TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 26 U.S. TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 27 U.S.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 28 U.S.LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 29 U.S.SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 30 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 31 U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 32 CANADA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 33 CANADA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 34 CANADA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 35 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 36 CANADALIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 37 CANADASOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 38 CANADA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 39 CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 40 MEXICO TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 41 MEXICO TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 42 MEXICO TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 43 MEXICOSEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 44 MEXICOLIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 45 MEXICOSOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 46 MEXICO TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 47 MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 48 EUROPE TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 49 EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 50 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 51 EUROPE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 52 EUROPE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 53 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 54 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 55 EUROPE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 56 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 57 EUROPE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 58 EUROPE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 59 GERMANY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 60 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 61 GERMANY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 62 GERMANY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 63 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 64 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION TABLE 65 GERMANY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 66 GERMANY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 67 FRANCE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 68 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 69 FRANCE TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 70 FRANCE SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 71 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 72 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 73 FRANCE TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 74 FRANCE TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 75 ITALY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 76 ITALY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 77 ITALY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 78 ITALY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 79 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 80 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 81 ITALY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 82 ITALY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 83 UK TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 84 UK TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 85 UK TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 86 UK SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 87 UK LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 88 UK SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 89 UK TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 90 UK TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 91 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 92 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 93 SWITZERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 94 SWITZERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 95 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 96 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 97 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 98 SWITZERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 99 SPAIN TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 100 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 101 SPAIN TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 102 SPAIN SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 103 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 104 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 105 SPAIN TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 106 SPAIN TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 107 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 108 NETHERLAND TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 109 NETHERLAND TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 110 NETHERLAND SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 111 NETHERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 112 NETHERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 113 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 114 NETHERLAND TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 115 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 116 RUSSIA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 117 RUSSIA TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 118 RUSSIA SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 119 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 120 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 121 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 122 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 123 RUSSIA TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 124 TURKEY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 125 TURKEY TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 126 TURKEY SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 127 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 128 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 129 TURKEY TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 130 TURKEY TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 131 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 132 BELGIUM TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 133 BELGIUM TOPICAL DRUG DELIVERY FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 134 BELGIUM SEMI SOLID LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 135 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 136 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS,BY TYPE, 2015 – 2024 (USD BILLION) TABLE 137 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 138 BELGIUM TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION TABLE 139 REST OF EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 140 APAC TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 141 APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 142 APAC TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 143 APAC TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 144 APACSEMI-SOLIDTOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 145 APAC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 146 APAC SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 147 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 148 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 149 APAC TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 150 APAC TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 151 JAPAN TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 152 JAPAN. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 153 JAPAN.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 154 JAPAN. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 155 JAPAN. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 156 JAPAN. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 157 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 158 JAPAN. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 159 CHINA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 160 CHINA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 161 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 162 CHINA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 163 CHINA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 164 CHINA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 165 CHINA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 166 CHINA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 167 SOUTH KOREA TOPICAL DRUG DELIVERY MARKET, BY TYPE 2015 – 2024 (USD BILLION) TABLE 168 SOUTH KOREA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 169 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 170 SOUTH KOREA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 171 SOUTH KOREA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 172 SOUTH KOREA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 173 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 174 SOUTH KOREA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 175 INDIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 176 INDIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 177 INDIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 178 INDIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 179 INDIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 180 INDIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 181 INDIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024, (USD BILLION) TABLE 182 INDIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 183 AUSTRALIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 184 AUSTRALIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 185 AUSTRALIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 186 AUSTRALIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 187 AUSTRALIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 188 AUSTRALIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 189 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 190 AUSTRALIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 191 SINGAPORE TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 192 SINGAPORE. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 193 SINGAPORE.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 194 SINGAPORE. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 195 SINGAPORE. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 196 SINGAPORE. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 197 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 198 SINGAPORE. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 199 THAILAND TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 200 THAILAND. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 201 THAILAND.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 202 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 203 THAILAND. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 204 THAILAND. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 205 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 206 THAILAND. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 207 MALAYSIA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 208 MALAYSIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 209 MALAYSIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 210 MALAYSIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 211 MALAYSIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 212 MALAYSIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 213 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024, (USD BILLION) TABLE 214 MALAYSIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 215 INDONESIA TOPICAL DRUG DELIVERY MARKET, BYTYPE, 2015 – 2024 (USD BILLION) TABLE 216 INDONESIA. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 217 INDONESIA.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 218 INDONESIA. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 219 INDONESIA. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 220 INDONESIA. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 221 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 222 INDONESIA. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 223 PHILIPPINES TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 224 PHILIPPINES. TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION) TABLE 225 PHILIPPINES.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 226 PHILIPPINES. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 227 PHILIPPINES. SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION TABLE 228 PHILIPPINES. TRANSDERMAL DRUG MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 229 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY END USER , 2015 – 2024 (USD BILLION) TABLE 230 PHILIPPINES. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) TABLE 231 REST OF APAC TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 232 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 233 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 234 SOUTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 235 SOUTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 236 SOUTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 237 SOUTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 238 SOUTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 239 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 240 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 241 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 242 SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 243 BRAZIL TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION) TABLE 244 BRAZIL TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 245 BRAZIL TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 246 BRAZIL SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 247 BRAZIL LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 248 BRAZIL SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 249 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 250 BRAZIL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 251 REST OF SOUTH AMERICA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 252 MEA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) TABLE 253 MEA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 254 MEA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 255 MEA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 256 MEA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 257 MEA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 258 MEA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE,, 2015 – 2024 (USD BILLION) TABLE 259 GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION) TABLE 260 GLOBAL ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION) TABLE 261 MEA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 262 MEA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 263 SOUTH AFRICA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION) TABLE 264 SOUTH AFRICA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) TABLE 265 SOUTH AFRICA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION) TABLE 266 SOUTH AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 267 SOUTH AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION) TABLE 268 SOUTH AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION) TABLE 269 SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION) TABLE 270 SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION) TABLE 271 REST OF MEA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION)
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19